Soroush Salehian Dardashti

CEO Soroush Salehian Dardashti sold 275,349 shares for $6,764,660.15 via 10b5-1 plan on 2026-06-16

Soroush Salehian Dardashti, Chief Executive Officer of AEVA, executed 8 separate sales totaling 275,349 shares (275.3K shares) for $6,764,660.15 ($6.8M) at prices ranging from $24.34 to $27.09, reducing his holdings from 1,746,157 shares (1.75M shares) to 1,470,808 shares (1.47M shares), a net reduction of 15.8%. The transaction is part of a pre-arranged 10b5-1 trading plan, indicating these sales were scheduled rather than discretionary decisions made in response to current conditions. The company is unprofitable with net income of $-34,979,000.00 ($-35.0M) over its most recent full fiscal year, though revenue has grown 99.4% year-over-year. At the transaction prices, the stock was near its 52-week midpoint; current price of $23.49 now reflects a -39.5% decline from the 52-week high of $38.80. His cross-ticker track record shows an average 90-day return of +20.8% following prior sales, though at AEVA specifically, post-sale outcomes have been mixed—the May 2026 sale showed 30-day gains of +62.2%, while the January 2026 sale resulted in 90-day losses of -30.8%.

CEO Salehian sells 250,000 shares ($3.4M) via 10b5-1 plan at $13.45 avg; retains 1.88M shares

CEO Dardashti Soroush Salehian executed 2 separate sales totaling 250,000 shares for $3,362,281.58, reducing his holdings from 2,134,808 shares to 1,884,808 shares. This represents an 11.7% reduction in his stake. The transaction was conducted under a pre-arranged 10b5-1 trading plan, meaning it was scheduled and not discretionary. With 1.88M shares remaining, the CEO retains substantial equity in AEVA, indicating continued material ownership alignment with shareholders.

CEO Soroush Salehian sells 200,000 shares for $2.7M via scheduled 10b5-1 plan at AEVA

CEO Soroush Salehian executed 2 separate sales totaling 200,000 shares for $2,689,806.34 at blended average price $13.45 on 2025-08-13. This transaction was part of a pre-arranged 10b5-1 trading plan and therefore represents scheduled, non-discretionary activity rather than a discretionary trading decision. Post-transaction holdings of 2,134,808 shares represent an 8.6% reduction from pre-transaction holdings of 2,334,808 shares. The routine, formulaic nature of 10b5-1 plan execution limits the interpretive value typically assigned to insider sales, since the timing and quantity are predetermined rather than responsive to current valuation or business conditions.

AEVA CEO Soroush Salehian sells 250,000 shares for $3.9M under 10b5-1 plan on 2025-05-19

Chief Executive Officer Soroush Salehian executed 4 separate sales totaling 250,000 shares for $3,924,658.87 under a pre-arranged 10b5-1 trading plan, reducing holdings from 3,764,808 shares to 3,514,808 shares. The transactions occurred at prices ranging from $15.48 to $18.61 across the same trading day, with a blended average price of $15.70. As a scheduled transaction under a 10b5-1 plan, this sale reflects a predetermined trading schedule rather than discretionary action, and the CEO retains substantial equity holdings post-transaction. The magnitude of the sale ($3.9M) and reduction in holdings (-6.6%) are material enough to warrant visibility, though the scheduled nature of the trade limits inference about current management sentiment regarding AEVA's near-term prospects.

CEO Dardashti sold 200.0K shares at $5.36; stock now at $5.80 after 51.8% 30-day rally.

Dardashti Soroush Salehian, Chief Executive Officer, sold 200,000 shares (200.0K shares) at $5.36 on 2025-03-26, reducing his stake from 3,964,808 to 3,764,808 shares (-5.0% of pre-transaction holdings) and raising $1,071,580.00. The sale occurred during a sharp 30-day rally (+51.8%) that continued to $5.80 (current price, within 0.0% of the 52-week high). His cross-ticker track record shows 62.50% well-timed selling (a 90-day metric favoring insider sales that precede declines), but at AEVA specifically, only 2 of 5 prior sells were well-timed on the 90-day measure. The company remains unprofitable (net income $-37.4M in latest full year), though annual revenue growth accelerated at +110.2%. The sale's significance is tempered by the transaction price being 7.6% below current market value, the insider's continued large stake (3.76M shares), and mixed timing results on this specific ticker.

CEO Soroush Salehian sold 240,000 AEVA shares in two tranches for $1,059,536.72 (blended avg $4.41)

CEO Soroush Salehian executed 2 separate sales totaling 240,000 shares for $1,059,536.72 on December 2–3, 2024, reducing his stake by 5.7% to 3,964,808 shares post-transaction. The sales occurred at blended average price $4.41, slightly above the current market price of $4.31 and at a level 34.7% below the 52-week high of $6.60. At AEVA specifically, his prior 4 measurable sells show mixed timing outcomes—2 were well-timed at the 90-day mark (sales on 2024-09-04 and 2024-09-03, each followed by stock appreciation of +67.2% and +58.6%) and 2 were poorly timed (sales on 2024-03-22 and 2024-03-21, each followed by declines of -36.5% and -38.7%). The company remains unprofitable with net income of $-37,396,000.00 against quarterly revenue of $2,250,000.00, providing material context for insider liquidity actions.

AEVA CEO Dardashti sells 260,000 shares across 3 days (Sep 3-5) at blended avg $2.66 under 10b5-1 plan

CEO Dardashti Salehian executed 3 separate sales totaling 260,000 shares for $691,307.65 on 2024-09-03 through 2024-09-05, reducing his stake from 4,464,808 shares to 4,204,808 shares. The sales occurred at prices ranging from $2.84 to $2.55, with a blended average price of $2.66. Critically, this transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled in advance and not a discretionary market decision by the CEO. The multi-day execution and scheduled nature preclude any timing inference; the sales represent mechanical implementation of a predetermined plan rather than a response to current market conditions or company performance.